Rossari Total Liab vs Accounts Payable Analysis

ROSSARI Stock   826.15  18.40  2.18%   
Rossari Biotech financial indicator trend analysis is much more than just breaking down Rossari Biotech prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rossari Biotech is a good investment. Please check the relationship between Rossari Biotech Total Liab and its Accounts Payable accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Total Liab vs Accounts Payable

Total Liab vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Rossari Biotech Total Liab account and Accounts Payable. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Rossari Biotech's Total Liab and Accounts Payable is 0.96. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Rossari Biotech Limited, assuming nothing else is changed. The correlation between historical values of Rossari Biotech's Total Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Rossari Biotech Limited are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Liab i.e., Rossari Biotech's Total Liab and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.96
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Accounts Payable

An accounting item on the balance sheet that represents Rossari Biotech obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Rossari Biotech are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Rossari Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rossari Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current Tax Provision is estimated to decrease to about 316.8 M. The current Selling General Administrative is estimated to decrease to about 107.3 M
 2021 2022 2023 2024 (projected)
Interest Expense126.6M223.2M193.7M203.4M
Depreciation And Amortization480.6M629.3M603.9M320.0M

Rossari Biotech fundamental ratios Correlations

0.60.780.990.930.90.921.00.690.190.890.970.840.930.620.670.70.640.770.560.910.890.770.820.991.0
0.60.890.650.750.720.690.580.10.860.80.540.490.720.510.510.520.650.430.490.430.780.920.720.60.63
0.780.890.810.90.880.840.760.420.620.930.740.660.870.460.480.550.660.60.450.580.911.00.790.760.79
0.990.650.810.930.90.910.990.630.250.90.970.820.920.620.690.680.660.770.550.880.890.810.830.990.99
0.930.750.90.930.970.980.930.590.390.990.920.790.990.60.620.680.790.770.560.830.990.90.860.920.93
0.90.720.880.90.970.920.90.660.390.940.850.740.990.510.530.530.770.660.380.870.960.890.940.910.88
0.920.690.840.910.980.920.920.550.310.970.940.790.970.650.670.750.780.820.650.820.960.830.790.910.93
1.00.580.760.990.930.90.920.670.180.890.970.790.930.570.640.650.690.760.520.910.890.760.80.990.99
0.690.10.420.630.590.660.550.67-0.340.490.60.780.640.320.220.430.120.430.210.780.490.390.630.690.63
0.190.860.620.250.390.390.310.18-0.340.470.13-0.030.350.120.180.060.560.060.10.030.480.670.420.190.22
0.890.80.930.90.990.940.970.890.490.470.90.730.970.580.620.660.810.770.560.750.990.930.820.880.91
0.970.540.740.970.920.850.940.970.60.130.90.80.910.640.740.720.680.860.610.860.880.730.730.960.98
0.840.490.660.820.790.740.790.790.78-0.030.730.80.780.790.70.880.270.70.740.810.680.630.730.840.84
0.930.720.870.920.990.990.970.930.640.350.970.910.780.570.60.630.780.740.490.870.980.880.90.930.92
0.620.510.460.620.60.510.650.570.320.120.580.640.790.570.90.90.30.770.870.610.520.450.570.630.66
0.670.510.480.690.620.530.670.640.220.180.620.740.70.60.90.810.440.760.790.630.580.470.580.690.71
0.70.520.550.680.680.530.750.650.430.060.660.720.880.630.90.810.270.740.970.590.580.530.490.670.75
0.640.650.660.660.790.770.780.690.120.560.810.680.270.780.30.440.270.570.240.580.860.70.650.650.64
0.770.430.60.770.770.660.820.760.430.060.770.860.70.740.770.760.740.570.690.660.740.580.550.760.8
0.560.490.450.550.560.380.650.520.210.10.560.610.740.490.870.790.970.240.690.430.470.430.320.530.63
0.910.430.580.880.830.870.820.910.780.030.750.860.810.870.610.630.590.580.660.430.780.590.870.940.88
0.890.780.910.890.990.960.960.890.490.480.990.880.680.980.520.580.580.860.740.470.780.920.850.880.89
0.770.921.00.810.90.890.830.760.390.670.930.730.630.880.450.470.530.70.580.430.590.920.810.760.78
0.820.720.790.830.860.940.790.80.630.420.820.730.730.90.570.580.490.650.550.320.870.850.810.860.79
0.990.60.760.990.920.910.910.990.690.190.880.960.840.930.630.690.670.650.760.530.940.880.760.860.98
1.00.630.790.990.930.880.930.990.630.220.910.980.840.920.660.710.750.640.80.630.880.890.780.790.98
Click cells to compare fundamentals

Rossari Biotech Account Relationship Matchups

Rossari Biotech fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets4.7B5.6B12.6B13.7B15.7B7.9B
Short Long Term Debt Total45.3M669.3M84.3M739.3M1.2B1.2B
Other Current Liab111.1M190.7M157.1M1.1B1.3B1.4B
Total Current Liabilities1.5B1.5B2.9B3.5B4.2B2.2B
Total Stockholder Equity2.9B4.1B8.1B9.2B10.5B11.0B
Other Liab35.6M21.7M23.9M1.6B1.8B1.9B
Net Tangible Assets1.2B2.8B4.0B5.4B6.3B6.6B
Property Plant And Equipment Net1.1B1.7B3.5B3.3B4.3B2.1B
Current Deferred Revenue(329.7M)53.9M903.5M1.2B125.1M118.8M
Net Debt377.2M(152.1M)(290.5M)41.0M936.2M983.0M
Retained Earnings1.6B2.4B3.3B4.4B5.6B5.9B
Accounts Payable970.0M1.3B1.9B1.8B2.2B1.4B
Cash292.1M152.1M374.8M698.3M251.7M254.9M
Non Current Assets Total1.5B2.1B6.5B6.5B7.3B7.7B
Non Currrent Assets Other255.1M55.9M130.5M183.4M104.4M122.5M
Other Assets130.3M255.6M58.9M144.0M165.6M114.4M
Cash And Short Term Investments1.4B883.6M644.3M1.5B667.9M732.6M
Net Receivables941.4M1.5B3.0B(23.4M)4.3B4.5B
Common Stock Shares Outstanding49.3M51.9M55.2M55.4M55.3M53.1M
Short Term Investments1.2B731.5M269.5M819.5M416.2M477.7M
Liabilities And Stockholders Equity4.7B5.6B12.6B13.7B15.7B7.9B
Non Current Liabilities Total361.3M23.9M1.6B1.1B996.9M568.9M
Inventory581.7M953.5M1.9B1.9B2.8B3.0B
Other Current Assets290.8M242.2M500.8M3.8B4.9B5.2B
Other Stockholder Equity1.2B(2.5B)4.6B4.6B4.7B4.9B
Total Liab1.8B1.5B4.5B4.5B5.2B2.8B
Total Current Assets3.3B3.5B6.1B7.2B8.4B4.4B
Short Term Debt313.4M53.9M(714.9M)390.0M745.6M782.9M
Intangible Assets47.7M107.6M1.7B1.5B1.4B1.5B
Common Stock101.5M103.9M110.1M110.3M110.5M91.9M
Property Plant Equipment708.6M1.1B1.7B3.5B4.0B4.2B
Long Term Debt6.7M339.6M0.0349.3M333.2M349.9M
Net Invested Capital3.5B4.1B8.1B9.9B11.5B6.2B
Short Long Term Debt329.7M0.084.3M390.0M725.0M761.3M
Net Working Capital1.8B2.0B3.1B3.7B4.2B2.5B
Capital Stock101.5M103.9M110.1M110.3M110.5M106.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Rossari Stock

Balance Sheet is a snapshot of the financial position of Rossari Biotech at a specified time, usually calculated after every quarter, six months, or one year. Rossari Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Rossari Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Rossari currently owns. An asset can also be divided into two categories, current and non-current.